Physician profile
Rodney Ashir
NPI 1578592143
$2,785.58
in general payments reported to CMS, 2019-2025
20 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $161 · 2021: $197 · 2022: $770 · 2023: $483 · 2024: $431 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $773.01 | 2019-2024 | Xarelto |
| Pfizer INC. | $751.19 | 2022-2025 | |
| Boston Scientific Corporation | $194.56 | 2021-2023 | Watchman Flx, Watchman Access System |
| Abbvie INC. | $182.71 | 2023-2025 | Dalvance |
| E.R. Squibb & Sons, L.L.C. | $130.18 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $97.96 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $96.40 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Abbott Laboratories | $87.17 | 2024-2025 | Jot Dx |
| Alexion Pharmaceuticals, INC. | $84.72 | 2022 | |
| Novartis Pharmaceuticals Corporation | $60.41 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.11 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.25 | 2022-2025 | Lifevest |
| Fisher & Paykel Healthcare INC | $41.90 | 2022 | |
| Recordati_rare_diseases_inc. | $30.59 | 2025 | Isturisa |
| Medtronic Vascular, INC. | $29.52 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $27.38 | 2022 | |
| Mallinckrodt Enterprises LLC | $25.85 | 2019 | |
| Siemens Medical Solutions USA, INC. | $24.84 | 2019 | |
| Global Blood Therapeutics, INC. | $24.00 | 2020 | |
| Gilead Sciences, INC. | $15.83 | 2025 | Veklury |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Ashir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.